Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 11,324 shares at $69.42 ($772K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Seasonal sale ($772k) by Chief Operating Officer — this insider has traded TARS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 3,125 | $217K | 28.1% |
| 2 | $68.71 | 3,610 | $248K | 32.1% |
| 3 | $67.00 | 4,589 | $307K | 39.8% |
| Total | $68.21 avg | 11,324 | $772K | 100% |
| Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |
| TARS | SELL | 2024-03-19 | $299K | — | Filing → |